Carl Spana founded Palatin Technologies, Inc. Currently, he is President, Chief Executive Officer & Director at this company and President & Director at RhoMed, Inc. (a subsidiary of Palatin Technologies, Inc.).

In the past Dr. Spana was Research Associate at Bristol Myers Squibb Co., Vice President at Paramount Capital Investments LLC, Vice President at Paramount BioCapital Asset Management, Inc. and Vice President at Castle Group Ltd.

Carl Spana received a doctorate from The Johns Hopkins University and an undergraduate degree from Rutgers State University of New Jersey.